Proxima, a dedicated MedTech contract research organization, announced a change in company ownership in a statement released by Billy Howell, Chairman of the Board.

Biotech investors have not often looked at a balding head of hair and been struck with inspiration, even on the rare ...

Although rare kidney diseases remain a significantly overlooked contributor to the global burden of CKD, things have begun to ...

THIRD QUARTER IN BRIEFActive Biotech provided status update for the development of laquinimod in inflammatory eye disorders and tasquinimod in hematological malignancies (July 8)Active Biotech present ...

SSI International is not the only outlaw. Vyome Therapeutics, a biotech company based in Delhi, developed novel drugs for ...

Biotech Evommune and diagnostics startup BillionToOne will begin trading today, with venture investors avid to see public ...

Evommune raises $150M in an IPO during the federal shutdown using a securities law workaround, signaling a new path for ...

Market guru Anil Singhvi provides a detailed overview of sector-specific stock opportunities, noting potential gains in healthcare, FMCG, and fintech while advising caution on metals and select ...

Shares of Vigonvita Life Sciences surged in its Hong Kong debut, adding to the wave of Chinese healthcare and biopharmaceutical firms tapping the city's financial markets. The Suzhou-based company's ...

Chinese biotech firm Argo Biopharmaceutical Co. has picked banks for a Hong Kong initial public offering that could raise a ...

The immune drugmaker is the second biotech, along with MapLight Therapeutics, to recently use a workaround in U.S. securities ...

The wave of tech layoffs sweeping the Bay Area shows little sign of slowing, with new filings revealing job cuts at two major ...